IRISanRaf

BARBANTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.639
AS - Asia 3.427
EU - Europa 1.011
SA - Sud America 455
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 67
OC - Oceania 13
Totale 9.693
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.155
TR - Turchia 1.061
SG - Singapore 912
CN - Cina 719
CA - Canada 450
IT - Italia 387
BR - Brasile 343
VN - Vietnam 284
IN - India 94
FR - Francia 91
DE - Germania 88
HK - Hong Kong 81
GB - Regno Unito 73
UA - Ucraina 72
IE - Irlanda 71
EU - Europa 65
PK - Pakistan 59
RU - Federazione Russa 58
AR - Argentina 42
IL - Israele 37
FI - Finlandia 36
ID - Indonesia 36
NL - Olanda 31
BD - Bangladesh 25
ES - Italia 23
MX - Messico 21
EC - Ecuador 17
ZA - Sudafrica 17
SC - Seychelles 16
CO - Colombia 15
JP - Giappone 15
IQ - Iraq 14
VE - Venezuela 14
MY - Malesia 13
PL - Polonia 13
SE - Svezia 13
PH - Filippine 12
KE - Kenya 11
AU - Australia 10
CL - Cile 8
EG - Egitto 8
KZ - Kazakistan 7
PY - Paraguay 7
SA - Arabia Saudita 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
MA - Marocco 6
NP - Nepal 6
RO - Romania 6
TN - Tunisia 6
UZ - Uzbekistan 6
IR - Iran 5
KR - Corea 5
PT - Portogallo 5
RS - Serbia 5
TW - Taiwan 5
DK - Danimarca 4
JO - Giordania 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
BO - Bolivia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BB - Barbados 2
BE - Belgio 2
BG - Bulgaria 2
BW - Botswana 2
CR - Costa Rica 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
LB - Libano 2
LT - Lituania 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
MT - Malta 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
GP - Guadalupe 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
Totale 9.687
Salva come PNG Salva come JPEG
Città #
Kocaeli 926
San Mateo 664
Dallas 622
San Jose 541
Toronto 421
Ashburn 397
Singapore 270
Wilmington 223
Rome 210
Beijing 201
Santa Clara 196
Houston 182
Lawrence 140
Princeton 140
Ho Chi Minh City 115
Hong Kong 77
Fairfield 74
Los Angeles 63
Seattle 55
Hanoi 54
Chandler 49
West Jordan 46
Islamabad 45
Redwood City 43
Frankfurt am Main 41
São Paulo 41
Shanghai 40
New York 37
Woodbridge 34
Netanya 31
Brooklyn 29
Guangzhou 26
Helsinki 26
Cambridge 25
Dublin 24
Milan 19
Chicago 15
Jakarta 15
Council Bluffs 14
Orem 14
Shenzhen 13
Vicenza 13
Amsterdam 12
Haiphong 11
Kuala Selangor 11
London 11
Mexico City 11
Munich 11
Rio de Janeiro 11
Tokyo 11
Montreal 10
Nairobi 10
Suffern 10
Atlanta 9
Boston 8
Denver 8
Saint Petersburg 8
San Francisco 8
Andover 7
Biên Hòa 7
Charlotte 7
Chennai 7
Curitiba 7
Da Nang 7
Dhaka 7
Johannesburg 7
Mumbai 7
Philadelphia 7
Phoenix 7
Quito 7
Roubaix 7
Rui'an 7
Secaucus 7
The Dalles 7
Turku 7
Wuhan 7
Almaty 6
Ankara 6
Bexley 6
Florence 6
Ha Long 6
Pune 6
St Petersburg 6
Warsaw 6
Washington 6
Wroclaw 6
Wuxi 6
Ann Arbor 5
Belo Horizonte 5
Borås 5
Buenos Aires 5
Guayaquil 5
Hải Dương 5
Jiaxing 5
Kansas City 5
Karachi 5
Manchester 5
Miami 5
Paris 5
Quanzhou 5
Totale 6.628
Salva come PNG Salva come JPEG
Nome #
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 333
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine 135
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 132
Amitriptyline in preventive treatment of tension headaches in non-depressed patients is efficient for chronic, but not for episodic cases 127
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease 117
A case-control study on excessive daytime sleepiness in chronic migraine 104
A case-control study on excessive daytime sleepiness in chronic migraine 100
A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine 98
A case - control study on excessive daytime sleepiness in episodic migraine 98
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 96
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 88
Clinical features, disease progresson and use of healthcare resoiurces in a large sample of 866 patients from 24 headaches centers: a real-life perspective from the italian chronic migraiNE (IRON) project 86
Ketogenic diet in migraine: rationale, findings and perspectives 83
Hypertension as a risk factor for migraine chronification 80
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 78
Amitriptyline is effective in chronic but not in episodic tension-type headache: Pathogenetic implications 78
Acupuncture in cluster headache: Four cases and review of the literature 77
Restless legs syndrome is not associated with migraine with aura: a clinical study 76
Early (<= 1-h) vs. late (> 1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study 74
Prolonged muscular flaccidity: frequency and association with unilateral spatial neglect after stroke 74
A mechanism-based classification of pain in multiple sclerosis 73
Unilateral cranial autonomic symptoms in migraine 73
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation) 73
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study 73
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 73
Prolonged muscular flaccidity after stroke morphological and functional brain alterations 72
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study 71
Acute pathological laughter induced by sumatriptan 70
Dopamine hypersensitivity in migraine: Role of the apomorphine test 70
Migraine as a Cortical Brain Disorder 70
Association of 24-h productivity with 2-h pain-free rates following administration of a fast disintegrating/rapid release formulation of sumatriptan 69
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 69
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease 66
Machine learning approach to predict medication overuse in migraine patients 66
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial 65
Late motor recovery is influenced by muscle tone changes after stroke 65
Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes 65
Dopamine and migraine: Does Parkinson's disease modify migraine course? 65
Tardive dyskinesias in the elderly 65
Prolonged muscular flaccidity in stroke patients is associated with crossed cerebellar diaschisis 65
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 65
Pharmacotherapy for acute migraines in children and adolescents 65
Real-world insights on the management of migraine patients: an Italian nationwide study 65
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 64
Dopamine and migraine: does Parkinson's disease modify the course of migraine? 64
Cluster headache: management of acute attacks before triptans 64
A proposal for a national registry on chronic migraines 64
Migraine and Tourette syndrome 64
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 64
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment 63
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study 63
Treatment of tension-type headache: from old myths to modern concepts 63
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 63
Differences in short-term primary motor cortex plasticity as assessed by repetitive transcranial magnetic stimulation in migraine with and without aura 62
Tension type headache: a neuropsychological and neurophysiological study 62
Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations 62
The evaluation of difficulties with work-related activities caused by migraine: towards a specific questionnaire 62
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 61
Donepezil in the treatment of progressive supranuclear palsy 61
NON-INVASIVE VAGUS NERVE STIMULATION (NVNS) FOR THE ACUTE TREATMENT OF MIGRAINE WITHOUT AURA IN ADOLESCENTS: PRELIMINARY CLINICAL EXPERIENCE 61
Cerebral Transverse Sinus Morphology As Detected by MR Venography in Patients With Chronic Migraine 61
Open-label Pilot Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Menstrual Migraine and Menstrually Related Migraine 61
Erenumab during pregnancy: a case report in a patient with chronic migraine 61
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 60
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura 60
Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine 60
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 60
Comparison of frovatriptan plus dexketoprofen (25mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study 60
Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study 60
Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinic 60
Migraine and movement disorders 59
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study 59
Future trends in drugs for migraine prophylaxis 59
Association of LTA and SOD Gene Polymorphisms with Cerebral White Matter Hyperintensities in Migraine Patients 58
Creutzfeldt-Jakob disease and related disorders: Etiopathogenetic aspects 57
Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test 57
Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana 57
Migraine prophylaxis: what is new and what we need? 57
Look beyond COMT genotype for cathecolamines derangement in migraine: the biobim rs4818 and rs4680 polymorphisms study 56
Shortened cortical silent period in facial muscles of patients with migraine 56
Chronic migraine: treatability, refractoriness, pseudo-refractoriness 56
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial 56
Dopaminergic symptoms in migraine: a case series on 446 consecutive patients 55
Migraine attack delays gastric emptying: an ultrasonographic study 55
HEADACHE FREQUENCY AND CHARACTERISTICS IN CHRONIC COCAINE USERS: A CROSS SECTIONAL STUDY 55
Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based Study 55
Impairment of trigeminal sensory pathways in cluster headache 55
Trigeminal sensory pathway function in patients with SUNCT 54
Efficacy and Safety of Frovatriptan plus Dexketoprofen in Menstrual Related Migraine (MRM) 54
Socio-economic costs of migraine 54
Drugs targeting nitric oxide synthase for migraine treatment 53
Headache in chronic cocaine users: A cross-sectional study 53
Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire 53
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 53
Increased density of dopamine D-5 receptor in peripheral blood lymphocytes of migraineurs: A masker for migraine? 52
Cocaine and headache: a 2-year follow-up study in chronic cocaine users and literature review 52
Migraine and the extrapyramidal system 51
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project 51
Role of neurostimulation in migraine 50
Unilateral Cranial Autonomic Symptoms in Migraine: A Retrospective Case Series on 757 Patients 50
Totale 7.019
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.955
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.075 0 0 0 0 0 0 0 0 0 73 940 62
2021/20221.377 18 419 425 6 2 0 103 162 16 200 11 15
2022/2023468 319 8 4 18 16 5 12 16 16 26 22 6
2023/2024387 5 2 9 46 14 52 1 27 0 85 3 143
2024/20251.519 81 221 128 52 86 257 111 107 176 22 39 239
2025/20264.065 259 356 662 381 269 461 521 265 504 387 0 0
Totale 9.925